Showing results (2801-2810 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|August 24, 2004
Effects of parathyroid hormone on cancellous bone mass and structure in osteoporosisNaohisa MiyakoshiCurrent Pharmaceutical Design|August 24, 2004
Testosterone action on the Sertoli cell membrane: a KIR6.x channel related effectG F Wassermann, E S LossCurrent Pharmaceutical Design|August 24, 2004
Regulation of myometrial smooth muscle functionsF Hertelendy, T ZakarCurrent Pharmaceutical Design|August 24, 2004
Regulation of the activity of the human drug metabolizing enzyme arylamine N-acetyltransferase 1: role of genetic and non genetic factorsFernando Rodrigues-Lima, Jean-Marie DupretCurrent Pharmaceutical Design|April 14, 2004
Small molecule FLT3 tyrosine kinase inhibitorsMark Levis, Donald SmallCurrent Pharmaceutical Design|April 14, 2004
Tyrosine kinases as new molecular targets in treatment of inflammatory disorders and leukemiaFatih M Uckun, Chen MaoCurrent Pharmaceutical Design|April 14, 2004
Nonnucleoside inhibitors of adenosine kinaseArthur Gomtsyan, Chih-Hung LeeCurrent Pharmaceutical Design|April 14, 2004
Protein phosphatase inhibition: structure based design. Towards new therapeutic agentsJennette A Sakoff, Adam McCluskeyCurrent Pharmaceutical Design|April 14, 2004
Protein tyrosine phosphatases: strategies for distinguishing proteins in a family containing multiple drug targets and anti-targetsBrian T Hoffman, Melanie R Nelson, Keith Burdick, et al.Current Pharmaceutical Design|March 23, 2004
The role of ROS and RNS in regulating life and death of blood monocytesChristopher P Baran, Mandy M Zeigler, Susheela Tridandapani, et al.Pageof 1,008